SOUTH KOREA · OPENDART
ABL Bio Inc.
에이비엘바이오 · 298380 · KOSDAQ · Healthcare · Biotechnology
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
No exchange purchase by an insider is on record yet.
Other changes in holdings · 6
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2025-09-09 | Won Jong-hwa | Vice president | Exercise of appraisal rights(+) | 41,000 | DART ↗ |
| 2025-09-09 | Kim Jeong-dae | Vice president | Exercise of appraisal rights(+) | 50,000 | DART ↗ |
| 2025-02-27 | Lee Jae-cheon | Vice president | Exercise of appraisal rights(+) | 17,175 | DART ↗ |
| 2025-02-05 | LEESANGHOON | CEO | 증여(-) | 10,000 | DART ↗ |
| 2024-11-05 | Won Jong-hwa | Vice president | 주식매수선택권(+) | 5,000 | DART ↗ |
| 2023-01-05 | LEESANGHOON | CEO | 증여(-) | 25,000 | DART ↗ |